Expert Analysis

10 Noteworthy CFPB Developments From 2024

In a banner year for consumer finance regulation, the Consumer Financial Protection Bureau made significant stride... (more story)

The Future Of GLP-1 Policy After Drug Shortage Ends

If and when the U.S. Food and Drug Administration determines that GLP-1 RA drugs are no longer in short supply, re... (more story)

Top 10 Whistleblowing And Retaliation Events Of 2024

From a Florida federal court’s ruling that the False Claims Act’s qui tam provision is unconstitutional to a recor... (more story)

Deals & Corporate Governance More

TD Bank, Boeing And Medicare: Compliance Headlines In 2024

Corporate compliance lessons were never far from the headlines in 2024, as regulatory challenges and headaches facing industries ranging from healthcare to aerospace played front and center, including TD Bank'... (more story)

Proskauer Beats DQ Bid In NJ Hospital Antitrust Fight

A New Jersey federal judge refused to disqualify Proskauer Rose LLP from defending healthcare network RWJBarnabas Health Inc. in an antitrust lawsuit brought by competitor CarePoint Health Management Associate... (more story)

Independent Health Inks $98M Deal For Medicare Overcharges

Independent Health Association Inc. has agreed to pay up to $98 million to resolve a decade-old False Claims Act whistleblower suit alleging it knowingly submitted invalid diagnosis codes for Medicare Advantag... (more story)

Top Government Contracts Of 2024: Year In Review

This year, the U.S. General Services Administration made dozens of awards for two massive, uncapped governmentwide deals, while the U.S. Department of Energy awarded more than $70 billion both for making nucle... (more story)

Top Gov't Contracts Cases Of 2024

Courts and the U.S. Government Accountability Office have made several high-profile, consequential decisions for government contractors this year, addressing the constitutionality of the False Claims Act's whi... (more story)

Pharma Trial Consultant To Pay SEC $3M Over Insider Trading

An oncologist and clinical professor at the University of California, Irvine agreed to pay the U.S. Securities and Exchange Commission $3 million to resolve allegations he purchased shares in a Massachusetts b... (more story)

Digital Health & Technology More

Medical Records Co. Wants Rival's Antitrust Suit Tossed

Epic Systems Corp. told a New York federal court that an antitrust case lodged by Particle Health Inc. is really just payback for revealing concerns that Particle allowed its customers to inappropriately acces... (more story)

Top Privacy & Cybersecurity Developments Of 2024

The state data privacy law patchwork continued to add new and varied pieces in 2024, while major hacks shook up the healthcare industry and other critical sectors, and the first U.S. laws setting guardrails fo... (more story)

Google Health Tracking Plaintiffs Fight To Keep Suit Alive

A California federal judge who was asked by Google to toss a proposed class action alleging that the tech giant illicitly scoops up users' personal data from healthcare providers' websites indicated during a T... (more story)

UNC Doctor Can't Shield Minor Transgender Patients' Records

A University of North Carolina doctor cannot assert privilege over medical records sought from the university by state Republicans fighting a suit by the physician and others seeking to enjoin a law imposing l... (more story)

Stanford Profs Say Roche's Trade Secret Claims Time-Barred

Stanford University's trustees and three of its professors have asked a California federal court to dismiss trade secret theft claims bought by subsidiaries of F. Hoffmann-La Roche AG, arguing that the allegat... (more story)

New Fed Health Data Rules: What You Need To Know

The Biden administration this week established long-awaited regulations codifying how medical providers and vendors must share electronic health information. New provisions were included to thwart criminal inv... (more story)

Policy & Compliance More

Sens. Aim To Protect Generics With Skinny Labels In New Bill

A bipartisan group of senators from Colorado, Arkansas, Vermont and Maine have introduced a bill that would shield generic-drug and biosimilar manufacturers from infringement liability when using approved "skinny labels."

3rd Circ. Denies Challenge To Pa. Autism Settlement

A Third Circuit panel on Friday rejected claims a settlement requiring around-the-clock care for a woman with autism is too impractical to be enforced, reversing a lower-court decision and handing a victory to... (more story)

Psychedelics Law Reformers Hit Multiple Setbacks In 2024

In 2024, advocates, physicians and researchers attempted to broaden lawful access to federally illegal psychedelic drugs through a variety of avenues — the new drug approval process, litigation and a ballot in... (more story)

Lambda Legal Adds Attorney In NY Focused On Trans Rights

LGBTQ+ advocacy group Lambda Legal has hired a new senior attorney focused on the organization's work defending the transgender community.

Top NJ Cases Of 2024: COVID Test Kits And Political Favors

After failed attempts in previous years, 2024 was the year prosecutors secured convictions in separate cases against a longtime New Jersey senator and a healthcare software executive. In another closely watche... (more story)

PhRMA Wins Bid To Halt W.Va. Drug Discount Expansion Law

The country's biggest pharmaceutical lobbying group has won preliminary injunctions against a West Virginia law that the Pharmaceutical Research and Manufacturers of America claims unconstitutionally expands a... (more story)